Pay in 4 interest-free payments of $6.44 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
FOXO4-DRI acts as a decoy that competes with FOXO4 for p53
described in the original 1998 preclinical characterisation also carries indirect safety relevance [1]
Look for products that use shelf-stable technology or are shipped in a way that preserves their viability
Generally safe when administered professionally
Instead of beginning with Which peptide should I take? the process begins with the patients symptoms, goals, medical history, medications, nutrition, recovery patterns, prior injuries, and risk factors
US$ 20.20
US$ 21.98
US$ 20.63
US$ 27.75
